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Son et al. find that the leucine metabolite,
acetyl-coenzyme A, promotes mTORC1
activity through EP300-mediated
acetylation of Raptor, an mTORC1
regulator. The pathway that is cell-type
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Raptor acetylation decreases in some
tissues, leading to mTORC1 inhibition..
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The mechanistic target of rapamycin (mTOR) com-
plex 1 (mTORC1) is a master regulator of cell growth
and metabolism. Leucine (Leu) activates mTORC1
and many have tried to identify the mechanisms
whereby cells sense Leu in this context. Here we
describe that the Leu metabolite acetyl-coenzyme A
(AcCoA) positively regulates mTORC1 activity by
EP300-mediated acetylation of the mTORC1 regu-
lator, Raptor, at K1097. Leu metabolism and conse-
quentmTORC1 activity are regulated by intermediary
enzymes. As AcCoA is a Leumetabolite, this process
directly correlates with Leu abundance, and does
not require Leu sensing via intermediary proteins,
as has been described previously. Importantly,
we describe that this pathway regulates mTORC1
in a cell-type-specific manner. Finally, we observed
decreased acetylated Raptor, and inhibitedmTORC1
and EP300 activity in fasted mice tissues. These
results provide a direct mechanism for mTORC1
regulation by Leu metabolism.
INTRODUCTION
The evolutionarily conserved mechanistic target of rapamycin
(mTOR) complex 1 (mTORC1) is a master regulator of cell growth
and metabolism (Jewell et al., 2013; Laplante and Sabatini,
2012), and comprises mTOR, regulatory-associated protein of
mammalian target of rapamycin (Raptor), mTOR-associated
protein, LST8 homolog, proline-rich Akt substrate of 40 kDa,
and DEP domain-containing mTOR-interacting protein (Laplante
and Sabatini, 2012). Dysregulation of mTORC1 is common in
human diseases, including cancer, diabetes, and neurodegener-
ative diseases, such as Alzheimer’s disease and Parkinson’s dis-
ease (Laplante and Sabatini, 2012; Saxton and Sabatini, 2017;
Zoncu et al., 2011). In mammals, growth factors and intracellular
energy signals stimulate mTORC1 activity through inhibition of
the tuberous sclerosis complex (TSC) 1 and 2, a negative regu-
lator of mTORC1 (Dibble and Manning, 2013). Amino acids192 Cell Metabolism 29, 192–201, January 8, 2019 ª 2018 The Autho
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of the TSC complex (Jewell et al., 2013; Sancak et al., 2008). Pre-
vious reports showed that Rag heterodimers interact with
mTORC1 and that AAs induce the mTORC1-Rag interaction by
promoting the loading of RagB with GTP, enabling it to directly
interact with Raptor (Sancak et al., 2008). Activation of the
mTORC1 pathway by AAs correlates with the translocation of
mTORC1 from undefined locations to lysosomes where it en-
counters RHEB, a potent mTORC1 activator (Efeyan et al.,
2012; Sancak et al., 2008). The Ragulator complex, which is en-
coded by theMAPKSP1, ROBLD3, and c11orf59 genes (Sancak
et al., 2010), interacts with the Rag GTPases, recruits them to
lysosomes, and is essential for mTORC1 activation (Sancak
et al., 2010).
Among AAs, leucine (Leu) has been implicated in mTORC1
activation (Hara et al., 1998; Sancak et al., 2008) and many
have searched for the Leu sensor(s) in cells that control mTORC1
activity (Han et al., 2012; Lorin et al., 2013; Saxton et al., 2016;
Wolfson et al., 2016; Zheng et al., 2016). Recently, Sestrin2, a
GATOR2-interacting protein that inhibits mTORC1 (Chantranu-
pong et al., 2014; Parmigiani et al., 2014; Saxton et al., 2016),
was reported as an intracellular Leu sensor for mTORC1
pathway in HEK293T cells (Wolfson et al., 2016). Other proposed
Leu sensors include leucyl-tRNA synthetase (LARS) (Han et al.,
2012; He et al., 2018) and glutamate dehydrogenase (GLUD1)
(Lorin et al., 2013). Here, by studying enzymes regulating the
metabolism of Leu to acetyl-coenzyme A (AcCoA), we have
discovered that Leu signaling to mTORC1 does not necessarily
require a ‘‘sensor’’ in some cell lines and primary cells, as AcCoA
positively regulates mTORC1 via Raptor acetylation.
RESULTS AND DISCUSSION
MCCC1, Which Regulates Leu Metabolism, Impacts
mTORC1 Signaling in HeLa Cells
To determine whether Leu catabolism can regulate mTORC1 in
HeLa cells, we knocked down MCCC1, a key enzyme in the
Leu metabolic pathway (Figure 1A) (Chu and Cheng, 2007),
which decreased levels of markers of mTORC1 activity: phos-
phorylated S6K1, 4E-BP1 (mTORC1 kinase substrates), and
S6 (S6K1 substrate) (Figure 1B). When MCCC1 cDNA was
transfected into MCCC1 knockdown cells, it rescued mTORC1
activity (Figure 1C). These data suggested that MCCC1 couldr(s). Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
(legend on next page)
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regulate mTORC1. MCCC1 knockdown did not obviously per-
turb mitochondrial morphology or cause any reactive oxygen
species (ROS) elevation, and N-acetylcysteine, an ROS scav-
enger, did not rescue mTORC1 inhibition in MCCC1 knockdown
cells (Figures S1A–S1C). Since treatment with Leu stimulates
lysosomal recruitment and activation of mTORC1 under AA star-
vation conditions, we determined whether MCCC1 similarly
affected the lysosomal translocation of mTORC1. When we
added Leu to AA-starved cells, mTORC1 appeared in puncta-
like structures that co-localized with LAMP1-positive vesicles
(late endosomes/lysosomes) in control cells (Figure 1D, left
panel), but the mTORC1 redistribution onto lysosomes was
reduced upon knockdown of MCCC1 (Figure 1D, right panel).
Similarly, under AA starvation conditions, neither Leu nor its
direct metabolite alpha-ketoisocaproate, which is upstream of
MCCC1 (Figure 1A), rescued the mTORC1 pathway in MCCC1
knockdown cells (Figures 1D and 1E). However, 3-hydroxy-3-
methylglutaryl-coenzyme A and 1 mMAcCoA (Figure S1D shows
that this results in physiologically relevant levels intracellularly),
Leu metabolites downstream of MCCC1 (Figure 1A), could
restoremTORC1 activity inMCCC1 knockdown cells (Figure 1F),
indicating that Leu catabolism is essential for mTORC1 regula-
tion. As we observed with MCCC1 knockdown, depletion of
AUH (the enzyme immediately downstream of MCCC1 in the
pathway from Leu to AcCoA; Figure 1A) decreasedmTORC1 ac-
tivity, and Leu treatment failed to rescue mTORC1 activity in AA-
starved, AUH knockdown cells (Figures S1E–S1G). To determine
whether other branched chain AAs can also regulate mTORC1,
we treated starved cells with isoleucine (Ile) and valine (Val).
Val had no effect, and only high concentrations of Ile could
rescue mTORC1 activity in AA-starved cells (Figure S1H).
AcCoA, the Final Leu Metabolite, Regulates mTORC1
under AA-Starved Conditions in Some Cell Types
Total and cytosolic AcCoA levels were decreased in both
MCCC1 knockdown HeLa cells and AA-starved HeLa cells (Fig-
ures 2A and 2B). Leu and dichloroacetate (DCA, which enhances
AcCoA levels by activating pyruvate dehydrogenase to produce
AcCoA from pyruvate rather than Leu; Marino et al., 2014)
rescued the reduction of AcCoA under AA starvation conditions
(Figure 2B). Leumetabolites, including AcCoA andDCA, rescued
mTORC1 inhibition by AA starvation (Figures S1H and 2C–2E).
To determine whether cytosolic AcCoA levels are important forFigure 1. MCCC1, Which Regulates Leu Metabolism, Modifies mTORC
(A) Leu metabolic pathway. Blue box shows MCCC1 protein.
(B) Control and MCCC1 knockdown (transfected with pool or four deconvolute
mTORC1 signal. Blots are representative of at least three independent experime
knocked down MCCC1. p-S6K1 (Thr389), p-S6 (Ser235/236), p-4E-BP1 (Thr37/4
(C) Re-introduction to MCCC1 knockdown HeLa cells with MCCC1 cDNA. Blots
(D) Control and MCCC1 knockdown HeLa cells were either left untreated, AA st
nostained with mTOR and LAMP1 antibodies as shown. Co-localization panels
positive lysosomes were determined using Volocity software. Values are mean ±
AA-starved cells (two-tailed t test); ns, not significant. Scale bars, 5 mmand 1 mm (e
NC, normal control.
(E) Immunoblots of control and MCCC1-knockdown HeLa cells with or withou
representative of at least three independent experiments (N = 3). *p < 0.05, **p <
cells; &&p < 0.01 versus MCCC1 knockdown cells. p-ULK1 (Ser757).
(F) Immunoblots of control and MCCC1-knockdown HeLa cells with or without 3-
versus control cells; #p < 0.05, ##p < 0.01 versus AA-starved cells. N = 3.
194 Cell Metabolism 29, 192–201, January 8, 2019this mTORC1 rescue in AA-starved HeLa cells, we knocked
down ATP citrate lyase (ACLY), which makes a major contribu-
tion to cytosolic AcCoA production in many cell types (Marino
et al., 2014). In ACLY knockdown HeLa cells, total and cytosolic
AcCoA levels were decreased (Figure 2F), and the increase of
mTORC1 activity mediated by Leu or DCA in-starved cells was
blunted (Figure 2G). Next, as we observed in HeLa cells, Leu
and DCA rescued the inhibition of mTORC1 resulting from AA
starvation in human neuroblastoma SH-SY5Y cells (Figure 2H).
Likewise DCA could rescue mTORC1 activity in Mccc1 knock-
down primary neurons (Figure 2I). Furthermore, we found that
Leu metabolites rescued mTORC1 inhibition resulting from AA
starvation in primary neurons, as we observed in SH-SY5Y or
in HeLa cells (Figure 2J), which we confirmed by immunostaining
with an anti-phosphorylated S6 antibody (Figure 2K). Consistent
with these data, mTORC1 redistribution onto lysosomes in pri-
mary neurons was reduced under AA starvation conditions,
and this was rescued by the addition of Leu or DCA (Figures
S2A and S2B). Interestingly, unlike HeLa and neuronal cells,
HEK293T cells showed different patterns of mTORC1 regulation
(Figures S2C–S2E), which did not appear to be obviously depen-
dent on Leu metabolism. We found that DCA could reverse
mTORC1 inhibition by AA starvation in epithelial cell lines
(MCF7 and MCF10A), a glial cell line (H4), and mesenchymal
stem cells, but not in primary mouse embryonic fibroblasts
(MEFs) and HEK293T cells (Figure S2F). We analyzed AcCoA
levels in cell lines where mTORC1 signaling after starvation
was sensitive/insensitive to DCA/AcCoA. Our data suggest
that non-responsiveness may occur either when cells have
very high AcCoA levels in nutrient replete media, or if they fail
to lower AcCoA levels after AA starvation (Figure S2G).
Next, we investigated the mechanism by which Leu metabo-
lites regulate mTORC1. Since Rag GTPase recruits mTORC1
to lysosomes (Jewell et al., 2013) and AA starvation with/without
Leu metabolites regulates mTORC1 lysosomal localization (Fig-
ures 1D and 2D), we assessed if the Ragulator complex on lyso-
somes influenced mTORC1 regulation by AcCoA. RagA and
RagB double knockdown or knockdown of LAMTOR1 (which an-
chors the Ragulator complex to lysosomes) abrogated the ability
of AcCoA to rescue mTORC1 inhibition in AA-starved HeLa cells
(Figure S3A). Addition of Leu or AcCoA to starved cells did not
alter the localization of the Rag complex on lysosomes (Fig-
ure S3B), indicating that Leu metabolites can regulate mTORC11 Signaling in HeLa Cells
d oligos) HeLa cells were used to determine whether MCCC1 can regulate
nts (N = 3). P- indicates phosphorylated protein. Note that oligo no. 2 has not
6).
are representative of at least three independent experiments (N = 3).
arved for 2 hr, or AA starved and then Leu was added for 0.5 hr, then immu-
show an overlap between mTOR and LAMP1 signals. The fraction of mTOR-
SEM. n = 50 cells. *p < 0.05, **p < 0.01 versus control cells; ##p < 0.01 versus
nlarged images). The experiment was repeated an additional two times (N = 3).
t Leu or alpha-ketoisocaproate (KIC) under AA-starved conditions. Blots are
0.01, ***p < 0.001 versus control cells; #p < 0.05, ##p < 0.01 versus AA-starved
hydroxy-3-methylglutaryl-coenzyme A (HCoA) or AcCoA. *p < 0.05, **p < 0.01
(legend on next page)
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in a Rag complex-dependent manner without altering the local-
ization of Rag complex. To determine whether known Leu
sensors are required for mTORC1 activity rescue by AcCoA in
AA-starved HeLa cells, we knocked down Sestrin (Sestrin 1, 2),
LARS, and GLUD1, and found that mTORC1 activity was
restored by DCA and partially by Leu (Figures S3C and S3D) in
all cases. While we cannot exclude that complete knockout of
these sensors would not have an effect, our data suggested
that partial loss of these sensors is not limiting for the pathway
we have described in HeLa cells, although the slightly blunted
response to Leu in the Leu sensor knockdown cells may reflect
roles for these pathways in addition to AcCoA biogenesis from
Leu in regulating mTORC1 activity after starvation.
mTORC1Regulation by AcCoA Is Associatedwith EP300
Acetyltransferase
To determine the exact mechanism by which AcCoA regulates
mTORC1 signal pathway under AA starvation conditions, we
checked acetylation levels in HeLa cells because AcCoA can
activate lysine (K) acetyltransferases (KATs) (Marino et al.,
2014; Pietrocola et al., 2015a). We found that starvation
decreased acetylation levels globally, and the treatment with
Leu and AcCoA rescued it (Figure S3E). We found that the acet-
ylation in the cytoplasm particularly was reduced significantly,
and MCCC1 knockdown mimicked starvation conditions (Fig-
ure S3F). Next, we investigated how alteration in acetylation
levels by AcCoA could regulate mTORC1. Because EP300 ace-
tyltransferase has been reported to regulate mTORC1 signaling
by AcCoA (Marino et al., 2014), we treated cells with the specific
EP300 inhibitors c646 and spermidine (Pietrocola et al., 2015b).
We found that these compounds or EP300 knockdown blocked
the ability of AcCoA to rescue mTORC1 activity in AA-starved
HeLa cells (Figures 3A and 3B). However, knockdown of other
common acetyltransferases, KAT2A and KAT2B, did not block
the effect of AcCoA on mTORC1 activity under AA starvation
(Figure 3C). Consistent with these data, the EP300 activator
CTB, a simplified analog of CTPB, rescued mTORC1 inhibition
by AA starvation (Figure S3G). To determine whether the acetyl-
transferase activity of EP300 is important for mTORC1 regula-Figure 2. AcCoA, the Metabolite of Leu Metabolism, Is Important for m
(A) Measurement of total and cytosolic AcCoA levels in control and MCCC1 kno
(B) Measurement of total and cytosolic AcCoA levels on HeLa cells with or with
#p < 0.05, ##p < 0.01 versus AA-starved cells. N = 4.
(C) mTORC1 regulation under AA-starved conditions with or without Leu, KIC, HC
experiments (N = 3).
(D) mTORC1 distribution to lysosomal membranes under AA starvation with or
(enlarged images).
(E) Quantification of (D). Values are mean ± SEM. n = about 60 cells. **p < 0.01 ve
t test).
(F) Measurement of total and cytosolic AcCoA levels in control and ACLY knock
(G) Immunoblots of control and ACLY knockdown HeLa cells with or without Leu
independent experiments. N = 3.
(H) mTORC1 regulation under AA-starved conditions with or without Leu or DC
##p < 0.01 versus AA-starved cells (two-tailed t test). NC, normal control; NEA, n
(I) The role of DCA in Mccc1 knockdown primary neurons. **p < 0.01 versus contro
infected neurons. N = 3.
(J) mTORC1 regulation under starved condition with or without Leu, KIC, HCoA, or
versus starved neurons. N = 3.
(K) mTORC1 regulation using phosphorylated S6 (p-S6; Ser235/236) antibody in p
control neurons; #p < 0.05 versus starved neurons (two-tailed t test). Scale bar, 1
196 Cell Metabolism 29, 192–201, January 8, 2019tion, we used an EP300 acetyltransferase activity-dead mutant
(EP300 Mut), and found that EP300 Mut failed to rescue
mTORC1 signal by AcCoA in EP300 knockdown cells, while
rescue was seen with the wild-type (EP300 WT) protein (Fig-
ure 3B). Likewise, immunostaining showed that EP300 knock-
down prevented the lysosomal relocalization of mTORC1 in
response to AcCoA (Figure 3D). EP300 did not appear to regulate
mTORC2 activity (assessed by phosphorylation of PKCa/b or
AKT) (Figure 3E).
To investigate how starvation regulates EP300 activity, we
measured EP300 activity directly in total lysates and found that
starvation for 2 hr did not alter total EP300 activity (Figure S3H).
Consistent with previous reports showing that starvation altered
EP300 localization (Sebti et al., 2014), we found that EP300 was
located both in the nucleus and cytoplasm in basal conditions,
and that AA starvation caused it to relocalize predominantly
into the nucleus (Figure 3F). Likewise, AA starvation decreased
the activity of cytoplasmic EP300 (Figure 3G). The addition of
Leu and AcCoA to AA-starved cells caused a partial redistribu-
tion of EP300 into the cytoplasm from the nucleus (Figure 3H).
Consistent with these data, AA starvation increased the acetyla-
tion of histone H3, a nuclear EP300 substrate, while acetylation
of a cytoplasmic EP300 substrate, ATG7, was decreased (Fig-
ure 3I). These data indicate that mTORC1 regulation by AcCoA
under AA starvation conditions is associated with changes in
cytoplasmic EP300 acetyltransferase activity.
Raptor Acetylation by EP300 Is Important for mTORC1
Regulation
Having established that EP300 is able to modulate mTORC1 ac-
tivity and its translocation to the lysosomes (Figure 3), we next
investigated the mechanism for this effect. EP300 small inter-
fering RNA or chemical inhibition did not alter the localization
of Rag complex on the lysosome (Figure S3I), suggesting that
EP300 acted upstream of this complex and that it may interact
directly withmTORC1.We therefore assessedwhich component
of mTORC1 bound EP300, and found that only Raptor interacted
with it (Figures 4A, S4A, and S4B) independently of EP300 activ-
ity (Figure S4B). Furthermore, we were able to demonstrate thatTORC1 Regulation in Some Cell Types
ckdown HeLa cells. **p < 0.01 versus control cells. N = 3.
out Leu or DCA under AA-starved conditions. **p < 0.01 versus control cells;
oA, or DCA in HeLa cells. Blots are representative of at least three independent
without Leu, KIC, DCA, or AcCoA in HeLa cells. Scale bars, 5 mm and 1 mm
rsus control cells; ##p < 0.01, ###p < 0.001 versus AA-starved cells (two-tailed
down HeLa cells. **p < 0.01 versus control cells. N = 3.
or DCA under AA-starved conditions. Blots are representative of at least three
A in SH-SY5Y cells. **p < 0.01, ***p < 0.001 versus control cells; #p < 0.05,
on-essential AA mixture; EA, essential AA mixture. N = 4.
l small hairpin RNA (shRNA)-infected neurons; #p < 0.05 versusMccc1 shRNA-
DCA on primary neurons. *p < 0.01, **p < 0.01 versus control neurons; #p < 0.05
rimary neurons. Values are mean ± SEM. n = about 50 cells. **p < 0.01 versus
0 mm.
(legend on next page)
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Raptor is acetylated, and that this acetylation was reduced by AA
depletion (Figures 3I and 4B) or EP300 inhibition with c646 (Fig-
ures S4C and S4D), while the EP300 activator CTB increased
Raptor acetylation (Figure S4E). Consistent with Figure 3C,
neither KAT2A nor KAT2B induced Raptor acetylation (Fig-
ure 4C). We next determined which site in Raptor could be acet-
ylated to regulate mTORC1. A previous study showed that K840
in Raptor can be acetylated and can regulate mTORC1 under
specific conditions (Ma et al., 2015). However, the Raptor
K840R mutant did not alter mTORC1 activity in AA-starved cells
with/without AcCoA (Figure S4F) and, unexpectedly, mutation of
K840 in Raptor did not prevent its acetylation in HeLa cells (Fig-
ure S4G). Recent liquid chromatography-mass spectrometry
data showed that K1097 in Raptor can be acetylated (Lundby
et al., 2012). We found that Raptor K1097R (KR) mutant had
reduced acetylation (Figure 4D) and cells where Raptor was
knocked down and replaced with Raptor KR failed to restore
the mTORC1 activity in AA starvation with AcCoA (Figure 4E).
Raptor KR did not alter the formation of mTORC1 (Figure S4H),
but bound less to the Rag complex (Figures 4F and 4G). Like-
wise, immunostaining showed that cells with Raptor KR had
decreased mTORC1 on lysosomal membranes (Figure 4H).
AcCoA Levels and Acetylation of Raptor Are Decreased
in Tissues of Fasted Mice
Finally, to confirm the relevance of this mTOR signaling pathway
in vivo, we assessed it in the brains of fastedmice. As seen for AA
starvation in primary neurons (Figures 2J, 2K, and S2A), brains of
fasted mice showed reduced mTORC1 activity (Figure S4I).
We were able to confirm that the levels of AcCoA, the levels of
acetylated Raptor and ATG7, and EP300 activity were also
decreased in mouse brains following fasting (Figures 4I, 4J,
and S4J–S4M). In addition to brain tissue, fasted mouse liver
and muscle both showed significantly decreased levels of acet-
ylated Raptor and significantly reduced AcCoA in the muscle
with a non-significant trend in liver (Figures 4I and 4J).
In conclusion, while previous studies have suggested that
cells require Leu sensing mechanisms to transduce nutrient sta-
tus to the machinery controlling mTORC1 activity (Zheng et al.,
2016), our study finds that Leu can signal directly via its metab-
olite AcCoA in some cell types. Increased AcCoA levels, whichFigure 3. mTORC1 Is Regulated by AcCoA via EP300 Acetyltransferase
(A) EP300 inhibitors (c646 and spermidine [Sp]) inhibit AcCoA-induced rescue of
(B) Effects of EP300 knockdown with replacement with wild-type (EP300WT) or ca
deprivation with or without AcCoA. *p < 0.05, **p < 0.01, ***p < 0.001 versus cont
versus EP300 knockdown cells (two-tailed t test); ns, not significant. N = 3.
(C) mTORC1 regulation by AcCoA in control HeLa cells or in EP300, KAT2A, or K
pendent experiments (N = 3).
(D) mTORC1 distribution onto lysosomal membranes on control and EP300 knock
are mean ± SEM. n = about 50 cells. *p < 0.05 versus control cells; #p < 0.05 ve
images).
(E) mTORC2 regulation by EP300 activity. *p < 0.05 versus control cells; #p < 0.05 v
(Ser473).
(F) Localization of EP300 to the nucleus under AA-starved conditions. N, nuclear; C
bar, 5 mm.
(G) Nuclear or cytoplasmic EP300 activities under AA-starved condition. *p < 0.0
(H) Change in EP300 localization under AA starvation with or without Leu or AcCo
starved cells (two-tailed t test). N = 3.
(I) Differential regulation of acetylation of nuclear (H3) and cytoplasmic (ATG7 and
198 Cell Metabolism 29, 192–201, January 8, 2019are found when Leu is added to AA-starved cells, activate the
acetylation of Raptor at K1097. This increases its interaction
with the Rag complex compared with unacetylated Raptor KR,
and thus enables mTORC1 activation (Figure S4N). Interestingly,
this mechanism appears to be relevant in a variety of cell types,
including neurons. However, it is not obvious in MEF cells and
HEK293T cells, which have been used prominently in this field
for identifying alternate Leu signaling pathways (Han et al.,
2012; Wolfson et al., 2016). This raises the possibility of cell-
type-specific modes of regulation of mTORC1.
Limitations of Study
While we observed that starvation of mice decreased levels of
AcCoA and Raptor acetylation in some tissues including the
brain, further work is required to determine which tissues
respond in this way to nutrient deprivation in vivo, and if these re-
sponses are different in cancers. It will be important to assess the
importance of this Leu-AcCoA-mTORC1 signaling pathway in
different tissues in vivo, in relation to other Leu-sensing mecha-
nisms. It would be interesting to test the speculation that these
different pathways whereby Leu regulates mTORC1 may act
with different kinetics in different tissues after starvation is initi-
ated in vivo.
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starvation. **p < 0.01 versus control cells. N = 3.
(C) Acetylation of Raptor by EP300, not by KAT2A or KAT2B. ***p < 0.001 versus
(D) Raptor K1097R mutant (KR) is not acetylated. WT, wild-type; KR, K1097R mu
(E) Cells were depleted of Raptor with small interfering RNA (siRNA) and reconstitu
absence of AA, the latter with/without AcCoA in HeLa cells. *p < 0.05, **p < 0.01
&p < 0.05 versus Raptor KR-expressing cells (two-tailed t test); ns, not significan
(F and G) Reduced interaction of Raptor KR mutant with the Rag complex using
(H) mTORC1 distribution onto lysosomal membranes in HeLa cells depleted of R
2 mm (enlarged images). n = about 40 cells. **p < 0.01 versus Raptor WT-expres
(I and J) Decreased AcCoA levels and acetylation of Raptor in fastedmice brains, li
for 1.5 hr followed by a second round of starvation for another 22.5 hr. The tissue s
acetylated Raptor (J) levels. *p < 0.05, **p < 0.01, ***p < 0.001 versus fed mice.
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Rabbit polyclonal anti-Actin Sigma Aldrich #A2066; RRID: AB_476693
Rabbit polyclonal anti-AKT Cell Signaling Technology #9272; RRID: AB_329827
Rabbit monoclonal anti-phospho-AKT (p-AKT) (Ser473) Cell Signaling Technology #4060; RRID: AB_2315049
Rabbit monoclonal anti-ATG7 (D12B11) Cell Signaling Technology #8558; RRID: AB_10831194
Rabbit polyclonal anti-ATP-Citrate Lyase (ACLY) Cell Signaling Technology #4332; RRID: AB_2223744
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Cell Signaling Technology #4331; RRID: AB_2257987
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Mouse monoclonal anti-Flag M2 Sigma Aldrich #F3165; RRID: AB_259529
Mouse monoclonal anti-GAPDH clone 6C5 Abcam #ab8245; RRID: AB_2107448
Mouse monoclonal anti-GFP Clontech #632375
Mouse monoclonal anti-GFP Clontech #632592; RRID: AB_2336883
Mouse monoclonal anti-HA.11 clone 16B12 Covance #MMS-101P; RRID: AB_2314672
Goat polyclonal anti-HA Novus Biologicals #NB600-362; RRID: AB_10124937
Rabbit polyclonal anti-Histone H3 Cell Signaling Technology #9715; RRID: AB_331563
Mouse monoclonal anti-LAMP1 clone H4A3 Developmental Studies
Hybridoma Bank, University
of Iowa
N/A
Rabbit monoclonal anti-LAMP1 Cell Signaling Technology #9091; RRID: AB_2687579
Rabbit monoclonal anti-mLST8 (86B8) Cell Signaling Technology #3274; RRID: AB_823685
Rabbit monoclonal anti-LAMTOR1/C11orf59 Cell Signaling Technology #8975; RRID: AB_10860252
Rabbit polyclonal anti-MCCC1 Novus Biologicals #NBP1-81254; RRID: AB_11033675
Mouse monoclonal anti-c-Myc clone 9E10 Roche #11667203001; RRID: AB_390911
Rabbit polyclonal anti-total p70S6kinase (S6K1) Cell Signaling Technology #9202; RRID: AB_331676
Rabbit monoclonal anti-phospho-p70S6kinase (p-S6K1) (Thr389) Cell Signaling Technology #9234; RRID: AB_2269803
Rabbit monoclonal anti-PRAS40 (D23C7) Cell Signaling Technology #2691; RRID: AB_2225033
Rabbit polyclonal anti-PKCa Cell Signaling Technology #2056; RRID: AB_2284227
Rabbit polyclonal anti-phospho-PKCa/b II (Thr638/641) Cell Signaling Technology #9375; RRID: AB_2284224
Goat polyclonal anti-Raptor SantaCruz Biotechnology #sc-27744; RRID: AB_2130790
Rabbit polyclonal anti-phospho-Raptor (Ser863) Signalway #12778
Rabbit monoclonal anti-Raptor (24C12) Cell Signaling Technology #2280; RRID: AB_561245
Rabbit polyclonal anti-phospho-Raptor (Ser792) Cell Signaling Technology #2083; RRID: AB_2249475
Rabbit monoclonal anti-RagA (D8B5) Cell Signaling Technology #4357; RRID: AB_10545136
Rabbit monoclonal anti-RagB Cell Signaling Technology #8150; RRID: AB_11178806
Rabbit monoclonal anti-RagC (D8H5) Cell Signaling Technology #9480; RRID: AB_10614716
Rabbit monoclonal anti-S6 Ribosomal Protein (S6) Cell Signaling Technology #2217; RRID: AB_331355
Rabbit anti-phospho-S6 Ribosomal Protein (p-S6) (Ser235/236) Cell Signaling Technology #4856; RRID: AB_2181037
Mouse monoclonal anti-a-Tubulin Sigma Aldrich #T9026; RRID: AB_477593
Rabbit polyclonal anti-mTOR Cell Signaling Technology #2972; RRID: AB_330978
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Rabbit polyclonal anti-phospho-mTOR (Ser2481) Cell Signaling Technology #2974; RRID: AB_2262884
Rabbit polyclonal anti-ULK1 Cell Signaling Technology #4773; RRID: AB_2288252
Rabbit anti-phospho-ULK1 (Ser757) Cell Signaling Technology #6888; RRID: AB_10829226
Chemicals, Peptides, and Recombinant Proteins
hEGF Sigma Aldrich #E9644
Hydrocortisone Sigma Aldrich #H0135
Cholera toxin Sigma Aldrich #C8052
Insulin Sigma Aldrich #I9278
KIC Sigma Aldrich #K0629
NAC Sigma Aldrich #A7250
DCA Sigma Aldrich #347795
HCoA Sigma Aldrich #H6132
AcCoA Sigma Aldrich #A2056
c646 Sigma Aldrich #SML0002
Spermidine Sigma Aldrich #S0266
Potassium hydroxycitrate tribasic monohydrate (HC) Sigma Aldrich #59847
TSA Sigma Aldrich #T8552
MitoTracker green FM Invitrogen # M7514
MitoSOX Red reagent Molecular Probes #M36008
Critical Commercial Assays
PicoProbe AcCoA assay kit Abcam #ab87546
SensoLyte EP300 assay kit Anaspec #AS-72172
GFP-TRAP Chromotek Gtma-20
Experimental Models: Cell Lines
HeLa ATCC #CCL-2; CVCL_0030
HEK-293T ATCC #CRL-3216; CVCL_0063
MCF7 ATCC #HTB-22; CVCL_0031
H4 ATCC #HTB-148; CVCL_1239
MCF10A Horizon #HD PAR-058
MSC ATCC #PCS-500-011
Primary mouse cortical neurons in-house N/A
MEF in-house N/A
Experimental Models: Organisms/Strains
C57BL/6 mice Jackson Laboratories C57BL/6
Oligonucleotides
Primer for Raptor K1097R forward primer, 5’-ccaaatcagcaaa
attcctccagaccctgatggca-3’
This paper N/A
Primer for Raptor K1097R reverse primer, 5’-tgccatcagggtct
ggaggaattttgctgatttgg-3’
This paper N/A
Primer for Raptor K840R forward primer, 5’-cacggtggccctgt
aggcgatgctgttgag-3’
This paper N/A
Primer for Raptor K840R reverse primer, 5’-ctcaacagcatcgc
ctacagggccaccgtg-3’
This paper N/A
For siRNA sequences see Table S1 N/A N/A
Recombinant DNA
pEFGP Clontech
pCMV6-XL5-MCCC1 Origene #SC113201
pcDNA3.1-EP300 Addgene #23252
pcDNA3.1-EP300(HAT-) Addgene #23254
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peYFP-C1-mTOR Addgene #73384
pRK5-HA-YFP-Raptor Addgene #73385
pRK5-HA-YFP-PRAS40 Addgene #73389
pRK5-HA-YFP-DEPTOR Addgene #73390
pRK5-HA-Raptor Addgene #8513
pRK5-HA-GST-RagB Addgene #19301
pLJM1-Flag-RagD Addgene #19316
pLJM1-Flag-Raptor-Rheb15 Addgene #26634
pLKO.1 shRNAs Dharmacon #RHS4080
mouse Mccc1 shRNA Dharmacon #RMM4534-EG72039
Software and Algorithms
Prism GraphPad https://www.graphpad.com/
scientific-software/prism/
ImageJ Fiji http://fiji.sc/
IMAGE STUDIO Lite LI-COR Biosciences https://www.licor.com/bio/
products/software/image_studio_lite/
Volocity PerkinElmer http://cellularimaging.perkinelmer.com/
Photoshop Adobe http://www.adobe.com/uk/products/
photoshop.html
Other
DMEM Sigma Aldrich #D6546
FBS Sigma Aldrich #F7524
FBS, dialyzed Thermo Fisher Scientific #26400-044
L-glutamine Sigma Aldrich #G7513
Penicillin/ streptomycin Sigma Aldrich #P0781
Horse serum Sigma Aldrich #H1270
Hank’s balanced salt solution Sigma Aldrich #H9394
Earle’s balanced salt solution Sigma Aldrich #E7510
leucine Sigma Aldrich #L8000
isoleucine Sigma Aldrich #I2752
valine Sigma Aldrich #V0500
Neurobasal-A medium Thermo Fisher Scientific #12349015CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, David C.
Rubinsztein (dcr1000@cam.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Lines
Human cervical epithelium HeLa, human neuroblastoma cell line SH-SY5Y, human embryonic kidney cell line HEK-293T, human
breast cancer cell line MCF7 and human neuroglioma cell line H4 cells (from ATCC) cultured in Dulbecco’s modified Eagle’s medium
(DMEM) (4.5 mg l-1 of glucose; #D6546)) supplemented with 10% FBS (#F7524), 2mM L-glutamine (#G7513) and 100Uml-1 penicillin
and 100 mgml-1 streptomycin (#P0781). Non-transformed mammary epithelial MCF10A cells were purchased from Horizon (Cata-
logue No. HD PAR-058) and cultured in DMEM-F12 supplemented with 5% horse serum (#H1270), 20 ngml-1 hEGF (#E9644),
0.5 mgml-1 hydrocortisone (#H0135), 100 ngml-1 cholera toxin (#C8052), 10 mgml-1 insulin (#I9278) and 100 Uml-1 penicillin and
100 mgml-1 streptomycin (all the components were obtained from Sigma Aldrich). A human adipose-derived Mesenchymal Stem
Cells (MSC) cell line was purchased from ATCC (#PCS-500-011), and maintained in Mesenchymal Stem Cell Basal Medium
(ATCC, #PCS-500-030), supplemented using theMesenchymal StemCell Growth Kit (ATCC, #PCS-500-040), according to the man-
ufacturer’s recommendation. All the cell lines were maintained at 37C and 5% CO2 and were regularly tested for mycoplasma
contamination. HeLa, SHSY5Y, HEK-293T, MCF7 and MCF10A cells are female, and H4 cells are male. For starvation experimentse3 Cell Metabolism 29, 192–201.e1–e7, January 8, 2019
with cell lines, cells were washed three times in Hank’s balanced salt solution (Invitrogen) and incubated for 2 h at 37C in Earle’s
balanced salt solution (Starvation media) (Sigma-Aldrich). All experiments with amino acid starvation and stimulation contained
10% dialyzed FBS (#26400-036 from Invitrogen) unless otherwise indicated. The cells were stimulated with essential amino acid
(AAs) at a concentration 2X of what is typically found in normal Invitrogen high-glucose DMEM.
Primary Mouse Cortical Neurons and Primary Embryonic Fibroblasts (MEFs)
Primary cortical neurons were isolated from C57BL/6 mice (Jackson Laboratories) embryos at E16.5 as described previously (Jime-
nez-Sanchez et al., 2015). Briefly, brains were harvested and placed in HBSS where the meninges were removed and the cerebral
cortices were dissected. After incubation in Hank’s Balanced Salt Solution (HBSS) with 0.25% trypsin (Gibco) for 20 min at 37C,
dissociated neurons were resuspended in HBSS and seeded on poly-D-lysine-coated 6- or 12-multiwell plates. Cells were cultured
in maintenance media (Neurobasal-A medium (#12349015, Thermo Fisher Scientific) supplemented with 2 mM GlutaMAX, 200 mM
B27 supplement and 1%Penicillin–Streptomycin) at 37C in a humidified incubator with 5%CO2. One half of the culturemediumwas
changed every 2 days until treatment/infection. After 5 days of in vitro culturing, differentiated neurons were infected with lentiviral
particles for knockdown experiments. Primary mouse embryonic fibroblasts (MEFs) were isolated from wild-type C57BL/6 mice em-
bryos at E12, using a protocol modified from that described previously (http://www.thermofisher.com/). The sexes of mouse-derived
primary cells were not determined, as this was not considered to impact the basic cell biology we are describing. All mouse exper-
iments were performed with personal and project licences granted by the UK Home Office and with the approval of the University of
Cambridge committee for animal studies.
Animals
For all studies, 6 to 7-weeks-old C57BL/6 male or female mice were used, and all studies were performed under the jurisdiction of
appropriate HomeOffice Project and Personal animal licences and with local Ethics Committee approval from the University of Cam-
bridge. The mice used in this study for obtaining the brains, livers and muscles were group-housed and maintained in cages with
standard bedding and enrichment. Mice were maintained in a temperature and humidity-controlled room on a 12 h light cycle
with ad libitum access to water and standard laboratory chow diet. Water and cages were autoclaved. The ratio of sexes of used
mice was 1:1 (for 48 h fasting) or only females were used for 23 h fasting experiment. In general, n=4-6 mice were used per group
and experiments were repeated at least twice. The number of the mice used for the experiments are indicated for each experiment
in the figure legends. No other inclusion or exclusion criteria were used. No significant differences of AcCoA levels or acetylated
Raptor levels between sexes were observed.
METHOD DETAILS
Antibodies and Reagents
The following antibodies have been used in this work: mouse anti-Flag M2 (#F3165), rabbit anti-Actin (#A2066) and mouse anti-
a-Tubulin (#T9026) from Sigma Aldrich; mouse anti-GAPDH clone 6C5 (#ab8245) and rabbit anti-AUH (#ab157453) fromAbcam; rab-
bit anti-MCCC1 (#NBP1-81254; Novus Biologicals); goat anti-Raptor (#sc-27744) and rabbit anti-EP300 (#sc-585) from SantaCruz
Biotechnology; mouse anti-GFP (#632375 and #632592; Clontech); rabbit anti-phospho-Raptor (Ser863; #12778; Signalway); mouse
anti-HA.11 clone 16B12 (#MMS-101P, Covance); mouse anti-EP300 (#05-257) from Millipore; mouse anti-LAMP1 clone H4A3
(obtained from Developmental Studies Hybridoma Bank, University of Iowa); mouse anti-c-Myc clone 9E10 (#11667203001; Roche);
rabbit anti-LAMP1 (#9091), rabbit anti-mTOR (#2972), rabbit anti-phospho-mTOR (Ser2481; #2974), rabbit anti-phospho-
p70S6kinase (p-S6K1) (Thr389; #9234), anti-total p70S6kinase (S6K1) (#9202), rabbit anti-phospho-S6 Ribosomal Protein (p-S6)
(Ser235/236; #4856), rabbit anti-S6 Ribosomal Protein (S6) (#2217), rabbit anti-phospho-4E-BP1 (Thr37/46; #9459), rabbit anti-
4E-BP1 (#9452), rabbit anti-phospho-ULK1 (Ser757; #6888), rabbit anti-ULK1 (#4773), rabbit anti-phospho-Raptor (Ser792;
#2083), rabbit anti-Raptor (24C12) (#2280), rabbit anti-acetylated-Lysine (Ac-K) (#9814, #9441), rabbit anti-Histone H3 (#9715), rabbit
anti-ATG7 (D12B11) (#8558), rabbit anti-PRAS40 (D23C7) (#2691), rabbit anti-mLST8 (86B8) (#3274), rabbit anti-LAMTOR1/C11orf59
(#8975), rabbit anti-RagA (D8B5) (#4357), rabbit anti-RagB (#8150) and rabbit anti-RagC (D8H5) (#9480), anti-phospho-PKCa/b II
(Thr638/641; #9375), anti-PKCa (#2056), anti-phospho-AKT (p-AKT) (Ser473;#4060), anti-AKT (#9272), anti-phospho-ATP-Citrate
Lyase (p-ACLY)(Ser455; #4331), anti-ATP-Citrate Lyase (ACLY) (#4332) from Cell Signaling Technology; anti-mouse (#NA931V)
and anti-rabbit (#NA934V) horseradish peroxidise (HRP)-conjugated secondary antibodies (GE Healthcare); anti-goat horseradish
peroxidise (HRP)-conjugated secondary antibody (#611620, Invitrogen/Life Technologies). All the primary antibodies were used at
a dilution of 1:1,000 (overnight incubation at 4C), unless otherwise stated, and the secondary antibodies used at a dilution between
1:2,000 and 1:4,000 (1 h of incubation at room temperature).
Drug treatments used include: DMSO, .1-10 mM leucine, .1-100 mM isoleucine, .1-100 mMvaline, 1-10 mMKIC, 1mMNAC, .1-1mM
DCA, 1-10 mMHCoA, .1-1 mM AcCoA, 10 mM c646, 10 mM Spermidine, 50 mMCTB, 20mM Potassium hydroxycitrate tribasic mono-
hydrate (HC), 50 mM TSA from Sigma-Aldrich.
Transfection
Trans IT-2020 reagent (Mirus) was used for DNA transfection, while Lipofectamine 2000 (Invitrogen) was used for siRNA trans-
fections, according to the manufacturer’s instructions. After transfection, cells were maintained in full medium. For knockdownCell Metabolism 29, 192–201.e1–e7, January 8, 2019 e4
experiments, unless otherwise specified in figure legends, cells were transfected with 50 nM siRNA followed by another 50 nM siRNA
transfection after 48 h. Cells were split once in between both transfections and harvested after 3 days of transfection. The following
DNA or siRNA/shRNA constructs were also used in this work: empty pEFGP and pcDNA3.1-myc-His (Invitrogen); pCMV6-XL5-
MCCC1 (untagged) (#SC113201) from Origene; pcDNA3.1-p300 (#23252), pcDNA3.1-p300(HAT-) (#23254), peYFP-C1-mTOR
(#73384), pRK5-HA-YFP-Raptor (#73385), pRK5-HA-YFP-PRAS40 (#73389), pRK5-HA-YFP-DEPTOR (#73390), pRK5-HA-Raptor
(#8513), pRK5-HA-GST-RagB (#19301), pLJM1-Flag-RagD (#19316), pLJM1-Flag-Raptor-RHEB15 (#26634) from Addgene. Pre-
designed siRNAs (SMARTpool and/or set of deconvoluted oligos ON-TARGETplus4Non-targeting Control #D-001810-10; RagA
#L-016070-00-0005, RagB #L-012189-01-0005, LAMTOR1 #L-020916-02-0005, AUH #L-008457-00-0005, HMGCL #L-019290-
00-0005, KAT2A #L-009722-02-0005, KAT2B #L-005055-00-0005, KAT5 #L-006301-00-0005, KAT8 #L-014800-02-0005, EP300
#L-003486-00-0005, Raptor #L-004107-00-0005, Sestrin 1 #L-020244-00-0005, Sestrin 2 #L-019134-02-0005, LARS #L-010171-
00-0005, ACLY #L-004915-00-0005) were obtained from Dharmacon-Thermo Scientific; For knockdown of MCCC1, we used siRNA
from Ambion (#AM51331, s32399, s32400, s32401) as well as from Dharmacon-Thermo Scientific (#L-009429-00-0005). For knock-
down of GLUD1, we used siRNA from Ambion (#AM16708, 107673). Pre-designed pLKO.1 shRNAs vectors from The RNAi
Consortium (TRC) (empty vector control #RHS4080, Dharmacon; mouse Mccc1 #RMM4534-EG72039). Although all the shRNAs
provided by TRC were validated, we used to perform most of the experiments (TRCN0000112506 (#B)).
Western Blot Analysis
The tissue samples were lysed in tissue lysis buffer on ice (20 mM Tris-HCl (pH7.4), 5 mM EDTA, 150 mM NaCl, 0.5% Triton X-100,
10 mM sodium butyrate, 1 mM TSA and protease/phosphatase inhibitors cocktail) and the supernatant was centrifuged twice. Pro-
tein concentration was determined using the Bradford assay (Bio-Rad). Cells were lysed in Laemmli buffer and protein samples were
boiled for 10 min at 100C, separated by SDS-PAGE, transferred onto PVDF membranes, subjected to western blot analysis, finally
visualized using an ECL enhanced chemiluminescence detection kit (GE Healthcare), or with direct infrared fluorescence detection
on an Odyssey Infrared Imaging System. Densitometric analysis on the immunoblots was performed using ImageJ program or
IMAGE STUDIO Lite software, which enables quantitative analysis of blotting signals.
Starvation for Primary Cortical Neurons
For starvation experiments with primary neurons, neurons were washed twice in either maintenance media or artificial CSF (ACSF)
(10mMHEPES, pH 7.4, 125mMNaCl, 5mMKCl, 2mMCaCl2, 1 mMMgCl2, 10mMglucose) and incubated inmaintenancemedia or
ACSF for 4 h.
shRNA Lentivirus Production and Infection
shRNA lentiviral particles were produced and transduced following The RNAi Consortium (TRC) protocols. Briefly, HEK-293T pack-
aging cells growing in 100 mm dishes were transfected at 60–70% of confluence with a mix of 2.5 mg psPAX2 vector (packaging vec-
tor), 270 ng pMD2.G vector (envelope vector) and 2.7 mg hairpin-pLKO.1 vector. TransIT-LT1 (Mirus) was used as transfection
reagent according to the manufacturer’s instructions. After transfection, cells were cultured in high-serum medium (20% FBS).
Cell culture medium was harvested three times for intervals of 24 h. Viral preps were then concentrated by centrifugation at
160,100g for 90 min. For primary neurons, 20 ml of viral preps were added to the cells in the presence of 4 mg/ml polybrene (Sigma
Aldrich) and were incubated for 24 h. The medium was replaced by full medium and cells were further incubated for an additional
4 days before testing the knockdown effects.
Food Deprivation in Mice
All animal studies were performed under the jurisdiction of appropriate Home Office Project and Personal animal licences and with
local Ethics Committee approval from the University of Cambridge. For fasting, we used two different procedures. Either, the
6-weeks-old C57BL/6 male or female mice were deprived of food for 48 h with free access to water throughout the procedure, as
described previously (Ashkenazi et al., 2017). After 22.5 h starvation, mice were given free access to food for 1.5 h followed by a
second round of starvation for another 22.5 h. Our rationale is that this procedure synchronises the starvation. Alternatively, mice
were deprived of food for 23 h with free access to water throughout the procedure. The tissues were collected and frozen for immu-
noblot and immunoprecipitation analysis.
Mutagenesis
Mutagenesis of the human Raptor was generated with QuikChange Site-Directed Mutagenesis Kit (Agilent Stratagene) according to
manufacturer’s instructions, using the set of primers:
1) 5’-ccaaatcagcaaaattcctccagaccctgatggca-3’ (forward), 5’-tgccatcagggtctggaggaattttgctgatttgg-3’ (reverse) to convert the
residue Lys1097 into an Arg (K1097R)
2) 5’-cacggtggccctgtaggcgatgctgttgag-3’ (forward), 5’-ctcaacagcatcgcctacagggccaccgtg-3’ (reverse) to convert the residue
Lys840 into an Arg (K840R)e5 Cell Metabolism 29, 192–201.e1–e7, January 8, 2019
DPN I digestion was performed after PCR and XL-10 gold-competent cells were transformed, and through sequencing, Raptor
mutants from a positive clone were selected.
Immunofluorescence
For immunofluorescence, the HeLa, HEK-293T or primary neurons were fixed for 5 min with ice cold methanol or for 10 min with 4%
paraformaldehyde (PFA). Concentration of the primary and secondary antibodies are described below. The mounting solution was
from Molecular Probes.
Dilution of primary antibodies. 1:300 rabbit anti-mTOR; 1:600 mouse anti-LAMP1; 1:300 anti-phospho-S6 Ribosomal Protein;
1:400 rabbit anti-acetylated-Lysine (Ac-K); 1:500 rabbit anti-RagC; 1:200 rabbit anti-EP300; 1:200 goat anti-Raptor; 1:600 goat
anti-HA (#NB600-362; Novus Biologicals); 1:1000 mouse anti-HA.11 clone 16B12.
The secondary antibodies Alexa 488, 555, 568, 594 or 647 goat anti-mouse, goat anti-rabbit or rabbit anti-goat were obtained
from Molecular Probes and used at 1:400. Imaging was conducted with LSM780 Zeiss confocal with 63X oil-immersion lense.
The colocalization was measured using Volocity software for Mander’s Overlap Coefficient (MOC) or Pearson’s correlation coeffi-
cient (PCC). These procedures were performed in a blinded fashion.
Cytosolic/Nuclear Fractionation
Cells were washed twice with ice-cold PBS and lysed with Buffer A (10 mM HEPES, 10 mM KCl, 0.1 mM EDTA, 0.4% NP-40, 1 mM
DTT and protease/phosphatase inhibitors cocktail) and incubated on ice for 20 min. After homogenization, the lysates were centri-
fuged at 16,100g at 4C for 10min. Supernatants containing cytosolic proteins were harvested and nuclear pellets were resuspended
with Buffer B (20 mM HEPES, 0.4 M NaCl, 1 mM EDTA, 10% glycerol, 1 mM DTT and protease/phosphatase inhibitors cocktail) and
incubated for 1 h on ice. After centrifugation at 16,100g for 10 min at 4C, the supernatants containing the nuclear proteins were
collected. Protein concentration was determined using the Bradford assay (Bio-Rad). For AcCoAmeasurement, non-denatured total
and cytosolic fractions were used, and for immunoblot, the fractions were denatured. Histone H3 or GAPDH were used as nuclear or
cytosolic control.
Acetyl-Coenzyme A (AcCoA) Measurement
The AcCoA content was determined on total or cytosolic fractions using the PicoProbe AcCoA assay kit (ab87546, Abcam) according
to manufacturer’s instructions. Briefly, after deproteinization using the perchloric acid, the CoASH Quencher and Quencher remover
were added into the sample to correct the background generated by free CoASH and succ-CoA. The sample was then diluted
with the reaction mix, and fluorescence was measured using a plate reader and the following settings: lex 535 nm; lem 587 nm.
Fluorescence was measured using a Versamax Tunable microplate reader (Molecular Devices). The acetyl-CoA standard curve
was made in the range of 0–100 pM and the correlation coefficient was 0.990 or higher.
EP300 Activity Assay
The EP300 activty was determined using the SensoLyte EP300 assay kit (AS-72172, Anaspec) with some modification. Briefly, cell
lysates or brain tissue lysates were incubated with AcCoA solution and substrates (H3) for 15 min at 37C. Developer solution was
added and incubated for 30 min at room temperature. The fluorescence was measured using a plate reader and the following
settings: lex 389 nm; lem 513 nm. Fluorescence was measured using a Versamax Tunable microplate reader (Molecular Devices).
Co-Immunoprecipitation (Co-IP)
Cells in 60 mm dishes were washed twice with PBS and lysed in ice-cold lysis buffer (40 mM HEPES (pH 7.4), 2 mM EDTA, 10 mM
pyrophosphate, 10mMglycerophosphate, and 0.3%CHAPS (for interaction ofmTORC1with Rag complex) or 0.5%Triton X-100 (for
IP with Ac-K antibody) and protease/phosphatase inhibitors cocktail, and further supplemented with 10 mM sodium butyrate and
1 mM TSA for IP with Ac-K antibody. Lysates were incubated on ice for 20 min and isolated by centrifugation at 16,100g for
10 min. Supernatants were transferred to new tubes; 1/10 of the sample was kept as input control, while the remaining lysate
was overnight incubated with primary antibodies at 4C with gentle agitation. Thereafter, Dynabeads-protein G (Life Technologies)
were added to the samples and incubated at 4C for 2 h. Beads were washed three times with lysis buffer and the immunoprecip-
itated proteins were eluted and denatured with 2 X Laemmli buffer and boiled for 5 min. For co-transfection experiments, HeLa cells
were transfected with the indicated plasmids as follows: 1000 ng or 500 ng myc-mTOR in pRK5 or peYFP-C1-mTOR; 500 ng HA-,
YFP-Raptor with or without point mutation in pRK5; 100 ng HA-GST-RagB in pRK5; 100 ng HA-GST-RagD in pRK5 or Flag-RagD in
pLJM1. The total amount of plasmid DNA in each transfection was normalized to 2 mg with empty pRK5. For analysis of acetylated
Raptor in tissues, we used tissue lysis buffer (20 mM Tris-HCl (pH7.4), 5 mMEDTA, 150mMNaCl, 0.5% Triton X-100, 10 mM sodium
butyrate, 1 mM TSA and protease/phosphatase inhibitors cocktail) and 150 mg of lysates was used for IP.
GFP-Trap for IP of GFP (or YFP)-Fusion Proteins
The IP of GFP or YFP-fusion proteins was performed using GFP-Trap (gtma-100, ChromoTek) according to manufacturer’s instruc-
tions with somemodification. Briefly, cells in 60 mm dishes were lysed in ice-cold lysis buffer (10 mMTris-HCl, pH 7.4, 150mMNaCl,
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20 ml of GFP-Trap slurry, and then the beads were washed 2 times with the wash buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl,
0.5 mM EDTA). 60 ml of 2X sample buffer were added, and boiled for 10 min at 100C, separated by SDS-PAGE.
Mitochondrial Morphology Analysis
Mitochondrial morphology was investigated using MitoTracker green FM (M7514, Invitrogen) according to manufacturer’s instruc-
tions. Briefly, control or MCCC1 siRNA transfected cells for 48 h were stained with 100 nMMitoTracker Green FM for 20 min to visu-
alize mitochondrial morphology and then washed 2 times with Opti-MEM. Images were captured with LSM880 Zeiss confocal with
63X oil-immersion lens and quantified using the ImageJ program. These procedures were performed in a blinded fashion.
Assessment of Oxidative Stress
For analyzing the oxidative stress on control or MCCC1 knockdown cells, cells were incubated in 2 mM of MitoSOX Red reagent
(Molecular Probes), which is a specific superoxide marker in mitochondria, and 500 nM of Mitotracker Green FM (Molecular Probes)
for 10 min at 37C. Fluorescent intensity and distribution were observed using LSM880 Zeiss confocal with 63X oil-immersion lense.
The intensity was measured using Volocity software.
QUANTIFICATION AND STATISTICAL ANALYSIS
Image Analysis
Volocity software (PerkinElmer) was used for analysis and processing of confocal images. For co-localization analysis of confocal
images, we used Mander’s Overlap Coefficient (MOC) or Pearson’s Correlation Coefficient (PCC). A minimum of 30 cells were
examined for each condition. All experiments were repeated at least three times. The background was fixed for all within-experiment
analyses. See details in the figure legends.
Statistical Analysis
Significance levels for comparisons between groups were determined with unpaired or paired two-tailed Student’s t-test using
GraphPad Prism 5 (GraphPad Software) or Excel (Microsoft Office), where appropriate. For western blots, protein levels were normal-
ized to total forms or a housekeeping protein, such as tubulin or GAPDH. All data were expressed as means ± standard error of the
mean (S.E.M). P values of < 0.05 were considered statistically significant. Sample sizes were chosen on the basis of extensive
experience with the assays we have performed. The experiments were appropriately randomized. We have not formally tested
whether the data met the assumptions of the statistical approach, but these assays and data are typically analysed in the literature
with the approaches we have used. The statistical parameters are specified within the figure legends.
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